Back to search
Preserved Ratio Impaired Spirometry
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Preserved Ratio Impaired Spirometry trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Preserved Ratio Impaired Spirometry trials you may qualify forDespite the globally varying high prevalence rate of the PRISm phenotype, there are no guidelines for its diagnostic evaluation and management. Further studies…
Preserved Ratio Impaired Spirometry (PRISm) describes individual with spirometry findings of forced expiratory volume (FEV1) and forced vital capacity (FVC) rat…
The investigators aim to make it easier to find people with undiagnosed long-term lung health problems (such as asthma, and chronic obstructive pulmonary diseas…
The goal of this observational study is to develop an advanced expiratory algorithm model utilizing exhaled breath volatile organic compound (VOC) marker molecu…
To evaluate the demographic characteristics of PRISm population in patients with pulmonary function tests recommended by outpatient physicians. To investigate…
Chronic obstructive pulmonary disease (COPD) is the most common chronic tract disease and the third leading cause of death worldwide. The treatment effect of CO…
The investigators aim to investigate how individuals attending primary healthcare (PHC) services in Brazil for treatment of non-communicable diseases (NCDs), id…
The investigators aim to evaluate whether it is feasible for healthcare professionals to implement a case-finding tool to identify individuals at high risk for…
This study will establish a registration research platform, a clinical research database and a biospecimen bank for the prevention and treatment of COPD with Ch…